Standard Biotools Inc (LAB)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $279.27M
Last updated: Nov 17, 2026 at 4:32 PM ET
Standard Biotools Inc (LAB) Stock Chart
Standard Biotools (LAB) has a latest price of $0.54 on Nov 17, 2026. Its price fell 56.5% over the past 12 months. The month-end price fell 69.3% over the 3 years through Oct 2026, a compound annual decline of 32.6%.
Price Chart
From Apr 2022 to Oct 2026, its highest month-end close was $3.00 in Aug 2023 and its lowest $0.61 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart LAB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LAB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 19.7%, and over 6 months it fell 46.1%.
| Period | Change |
|---|---|
| 1 month | -16.2% |
| 3 months | -19.7% |
| 6 months | -46.1% |
| 12 months | -56.5% |
| 12 months, with dividends | -56.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -69.3% | -32.6% |
Price by Year
Its best calendar year was 2023, when the price rose 88.9%, and its weakest was 2025, when it fell 26.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.61 | -52.3% |
| 2025 | $1.28 | -26.9% |
| 2024 | $1.75 | -20.8% |
| 2023 | $2.21 | +88.9% |
Trading Range
The price is 19.9% below its 50-day average of $0.67 and 37.5% below its 200-day average of $0.86.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.54 | |
| 50-day average | $0.67 | -19.9% |
| 200-day average | $0.86 | -37.5% |
Price Risk
Over 3 years, its largest fall from a peak was 81.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.17 |
| Largest fall, 1 year | -67.9% |
| Largest fall, 3 years | -81.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About LAB
What is LAB's 1-year price change?
Standard Biotools's price fell 56.5% over the past 12 months. With dividends included, the 12-month total return was -56.5%.
How has LAB stock done over the long term?
Standard Biotools's month-end price fell 69.3% over the 3 years through Oct 2026, a compound annual decline of 32.6%. These figures leave out dividends.
What is LAB's beta?
Standard Biotools's 1-year beta against the S&P 500 is 1.17, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 67.9%.
Is the LAB chart free?
Yes. Advanced Charting for LAB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
LAB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts